PP
FLGT icon

PDT Partners’s Fulgent Genetics FLGT Stock Holding History

PDT Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,984
Closed -$320K – 582
2023
Q3 		$320K Buy
+11,984
New +$409K 0.04% 464
2021
Q3 		– Sell
-3,415
Closed -$315K – 816
2021
Q2 		$315K Buy
+3,415
New +$273K 0.02% 609
2020
Q4 		– Sell
-7,820
Closed -$313K – 743
2020
Q3 		$313K Buy
+7,820
New +$245K 0.02% 546
2020
Q2 		– Sell
-27,091
Closed -$291K – 714
2020
Q1 		$291K Buy
+27,091
New +$377K 0.02% 482

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PDT Partners's FLGT Position: Q4 2023 in Review

PDT Partners sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 11,984 shares — an estimated $320K sold.

PDT Partners first reported a position in FLGT in Q1 2020 and held it in 4 quarters. The position peaked at $320K in Q3 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • PDT Partners reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • PDT Partners sold 11,984 Fulgent Genetics shares in Q4 2023, an estimated $320K.
  • PDT Partners first reported a position in Fulgent Genetics in Q1 2020 and held it in 4 quarters.
  • PDT Partners's Fulgent Genetics position peaked at $320K in Q3 2023.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on PDT Partners's 13F filing for Q4 2023, filed 14 Feb 2024.